Changing the Conversation on Cancer Diagnosis in Dogs Dr. Angelo Marco, DVM and Dr. Andi Flory, DVM join host Laura Reeves for an exciting conversation about advances in early cancer detection. PetDx’s OncoK9 test is able to “identify a biomarker of cancer that comes from cancer cells” from a simple blood draw, according to Dr. Flory. [caption id="attachment_10009" align="alignleft" width="308"] Dr. Andi Flory, DVM, Chief Medical Officer at PetDX.[/caption] Flory, Chief Medical Officer at PetDx, said the OncoK9 test has the potential to revolutionize our ability to detect cancer in patients, potentially even before they start to show signs and symptoms. While the blood test identifies a variety of cancers, it is most successful at finding the “big three:” Lymphoma, hemangiosarcoma and osteosarcoma. “Those big three,” Flory said, “that detection rate is really high. It's 85% and those are the most aggressive cancers that we see in dogs. So the fact that we have the potential ...